Clinical trial
Clinical Study on "Pain Control of Cervical Dilation by Lidocaine Solution Injected Into a Single-use Micro-non-invasive Injection Cervical Dilator"
NCT05955768 is registered in ClinicalTrials.gov with First People's Hospital of Hangzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on "Pain Control of Cervical Dilation by Lidocaine Solution Injected Into a Single-use Micro-non-invasive Injection Cervical Dilator"
- Lead sponsor
- First People's Hospital of Hangzhou
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 21, 2023
- Completion date
- August 31, 2026
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical dilatations